LDS buys Kaolectrolyte, Prodium
This article was originally published in The Tan Sheet
Executive Summary
Cedar Rapids, Iowa-based LDS Consumer Products acquires U.S. marketing, distribution rights to Kaolectrolyte oral rehydration therapy for infants, children under six and Prodium urinary tract infection treatment from Requa, firm announces June 6. Kaolectrolyte competes against Ross' Pedialyte, while Prodium competitors include J&J's Uristat and PolyMedica's Azo-Standard; all three contain active phenazopyridine 95 mg. LDS obtained exclusive U.S. sales and marketing rights to Wartner Wart Removal System in 2002 (1"The Tan Sheet" April 28, 2003, p. 4)...